CP-358,774

A drug used to treat certain types of non-small cell lung cancer. It is also used with gemcitabine hydrochloride to treat pancreatic cancer that cannot be removed by surgery or has spread to other parts of the body. It is being studied in the treatment of other types of cancer. CP-358,774 blocks a protein called epidermal growth factor receptor (EGFR), which may help keep cancer cells from growing. It is a type of EGFR tyrosine kinase inhibitor. Also called erlotinib hydrochloride, OSI-774, and Tarceva.

• Dailymed label info on CP-358,774
• FDA CP-358,774

CP-358,774 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski